Get started
DDD

DICOT PHARMA AB

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

DICOT chart


Full chart

Key stats


Market capitalization
‪434.91 M‬ SEK
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.0515 SEK
Net income (FY)
‪−44.16 M‬ SEK
Revenue (FY)
0.00 SEK
Shares float
‪1.05 B‬
Beta (1Y)
0.00

About DICOT PHARMA AB


Sector
Health Technology
CEO
Elin Trampe
Headquarters
Uppsala
Website
dicot.se
Founded
2015
ISIN
SE0011178458
FIGI
BBG00KT8LY53
Dicot Pharma AB is a pharmaceutical company, which engages in the research, development and distribution of pharmaceuticals. The company develops a modern potency drug that will treat erectile dysfunction and premature ejaculation better than existing drugs and is in the clinical phase. It also develops LIB-01 until clinical phase 2a and then accelerate and finance the drug development further together with pharma partners into a registered drug for the world market. The company was founded by Jarl Wikberg on March 5, 2015 and is headquartered in Uppsala, Sweden.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of DICOT is 0.2555 SEK — it has increased by 3.65% in the past 24 hours. Watch DICOT PHARMA AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange DICOT PHARMA AB stocks are traded under the ticker DICOT.
DICOT stock has risen by 16.14% compared to the previous week, the month change is a 54.66% rise, over the last year DICOT PHARMA AB has showed a 138.79% increase.
DICOT reached its all-time high on Aug 27, 2019 with the price of 6.9000 SEK, and its all-time low was 0.0960 SEK and was reached on Nov 13, 2023. View more price dynamics on DICOT chart.
See other stocks reaching their highest and lowest prices.
DICOT stock is 8.24% volatile and has beta coefficient of 0.00. Track DICOT PHARMA AB stock price on the chart and check out the list of the most volatile stocks — is DICOT PHARMA AB there?
Today DICOT PHARMA AB has the market capitalization of ‪438.47 M‬, it has increased by 5.99% over the last week.
Yes, you can track DICOT PHARMA AB financials in yearly and quarterly reports right on TradingView.
DICOT net income for the last quarter is ‪−10.20 M‬ SEK, while the quarter before that showed ‪−13.14 M‬ SEK of net income which accounts for 22.40% change. Track more DICOT PHARMA AB financial stats to get the full picture.
No, DICOT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, DICOT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DICOT PHARMA AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DICOT PHARMA AB technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DICOT PHARMA AB stock shows the neutral signal. See more of DICOT PHARMA AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.